Revolutionizing Patient Care: AI and Epigenetics at the Forefront of Precision Medicine
Discover how the powerful synergy of Artificial Intelligence and Epigenetics is transforming healthcare by enabling the diagnosis of virtually any disease from just a few drops of blood. This innovative approach delivers unprecedented precision, providing insights equivalent to over $100,000 worth of conventional diagnostics at a fraction of the cost. Join us to explore how integrating AI-driven epigenetic analysis into your practice can significantly enhance patient outcomes, streamline clinical decision-making, and usher in a new era of personalized medicine.
Speakers
-
Jeff Bland, PhDFunctional Medicine Founder and PioneerDr. Jeffrey Bland is a personable and highly respected thought leader who has spent more than four decades focused on the improvement of human health.
He is known worldwide as the founder of the Functional Medicine movement, which represents his vision for a care model that is grounded in systems biology and informed by research that he has a unique ability to synthesize. His pioneering work has created the Personalized Lifestyle Medicine Institute (PLMI), as well as the Institute for Functional Medicine (IFM), the global leader in Functional Medicine education. Since 1991, hundreds of thousands of healthcare practitioners have participated in PLMI and IFM programs, and this collective knowledge has positively impacted the lives of patients all over the world. -
Ryan SmithTruDiagnsoticRyan Smith is founder of TruDiagnsotic. Ryan received a BA in Biochemistry from Transylvania University before heading to medical school in 2013. After passing USMLE Step 1, he decided to leave and open up a pharmacy in the United States that focused on peptide synthesis and formulations for pharmaceutical preparations. That pharmacy, Tailor Made Compounding, became the 4th fastest growing company in healthcare in the US and grw to 80 million in revenue within 3 years. Through this pharmacy work, Ryan saw the value of preventative medicine. Many of the physicians Tailor Made served were treating age as a disease and a primary outcome but needed better tools to measure this process. As a result, Ryan exited Tailor Made in 2020 to create TruDiagnostic.
TruDiagnostic is a CLIA certified lab and health data company which specializes in understanding and reporting insights found through Epigenetic methylation data. Since starting in 2020, TruDiagnostic has created the largest private epigenetic database in the world with over 15,000 patients tested on the EPIC850k array. From this dataset, they have created many new algorithms to interpret methylation data including algorithms to predict inflammatory markers, disease diagnosis, telomere length, aging pace, immune cell subsets, cellular replication, and more. TruDiagnostics has also led research in the field with over 30+ clinical trials investigating the best ways to reverse these markers through diet, lifestyle, and prescription interventions. Currently, TruDiagnostic is working with collaborators from Duke, Harvard, Yale, UCSF, Ohio St. and more to uncover new insights from the methylome. TruDiagnostic is also the only commercial company on the market to offer 2nd or 3rd generation aging algorithms which have shown to be more predictive and precise than 1st generation aging clocks.
In addition to his work with pharmaceuticals, Ryan also consults with international pharmacies and has set up pharmacies in Thailand and Mexico. In addition, Ryan has developed novel supplements and cosmetic formulations with multiple 100M supplement brands and consults with clinics in the cash pay wellness space.
-
Dr. Matthew DawsonCEO, TruDiagnosticDr. Matthew Dawson, a leading innovator in the field of epigenetics, is dedicated to bridging cutting-edge genomic science with practical healthcare applications. After earning his medical degree from the University of Kentucky and completing an emergency medicine residency at the University of Utah, where he served as chief resident, Dr. Dawson practiced and taught at the University of Kentucky as an associate professor for seven years. His interest in genomics and epigenetics deepened as he recognized their potential to revolutionize how we understand aging, disease prevention, and human health.
As CEO of TruDiagnostic, Dr. Dawson oversees a groundbreaking mission to unlock the potential of epigenetic data, empowering individuals and researchers alike to make informed decisions about healthspan and longevity. Under his leadership, TruDiagnostic has become a leader in epigenetic testing and biological aging research, leveraging advanced DNA methylation technology to provide actionable insights into personal health and disease risk.
A passionate advocate for health optimization, Dr. Dawson’s expertise extends beyond traditional medicine, encompassing fitness, nutrition, and biohacking. He is a sought-after speaker, recently contributing to prestigious platforms such as the Personalized Lifestyle Medicine Institute (PLMI), where he is spearheading the integration of Epigenetic Biomarkers (EBPs) and Methylation Risk Scores (MRS) into preventive healthcare strategies. Dr. Dawson’s vision for TruDiagnostic focuses on making this emerging science accessible to both clinicians and the general public, driving a future where personalized health interventions are guided by precise epigenetic data.
